These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 35645695)

  • 1. Hematological Findings in Lysosomal Storage Disorders: A Perspective from the Medical Laboratory.
    Leal AF; Nieto WG; Candelo E; Pachajoa H; Alméciga-Díaz CJ
    EJIFCC; 2022 Apr; 33(1):28-42. PubMed ID: 35645695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysosomal storage disease overview.
    Sun A
    Ann Transl Med; 2018 Dec; 6(24):476. PubMed ID: 30740407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From bedside to cell biology: a century of history on lysosomal dysfunction.
    Coutinho MF; Matos L; Alves S
    Gene; 2015 Jan; 555(1):50-8. PubMed ID: 25275857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploiting the Potential of
    Rigon L; De Filippis C; Napoli B; Tomanin R; Orso G
    Biomedicines; 2021 Mar; 9(3):. PubMed ID: 33800050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiological and clinical characterization of the lysosomal storage disorders: non-lipid disorders.
    Parker EI; Xing M; Moreno-De-Luca A; Harmouche E; Terk MR
    Br J Radiol; 2014 Jan; 87(1033):20130467. PubMed ID: 24234586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme enhancement therapeutics for lysosomal storage diseases: Current status and perspective.
    Thomas R; Kermode AR
    Mol Genet Metab; 2019 Feb; 126(2):83-97. PubMed ID: 30528228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reproduction in Animal Models of Lysosomal Storage Diseases: A Scoping Review.
    Vuolo D; Do Nascimento CC; D'Almeida V
    Front Mol Biosci; 2021; 8():773384. PubMed ID: 34869599
    [No Abstract]   [Full Text] [Related]  

  • 8. A perspective on research, diagnosis, and management of lysosomal storage disorders in Colombia.
    Puentes-Tellez MA; Lerma-Barbosa PA; Garzón-Jaramillo RG; Suarez DA; Espejo-Mojica AJ; Guevara JM; Echeverri OY; Solano-Galarza D; Uribe-Ardila A; Alméciga-Díaz CJ
    Heliyon; 2020 Mar; 6(3):e03635. PubMed ID: 32258481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Finding pathogenic commonalities between Niemann-Pick type C and other lysosomal storage disorders: Opportunities for shared therapeutic interventions.
    Yañez MJ; Marín T; Balboa E; Klein AD; Alvarez AR; Zanlungo S
    Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165875. PubMed ID: 32522631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune system irregularities in lysosomal storage disorders.
    Castaneda JA; Lim MJ; Cooper JD; Pearce DA
    Acta Neuropathol; 2008 Feb; 115(2):159-74. PubMed ID: 17924126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme replacement therapy with recombinant pro-CTSD (cathepsin D) corrects defective proteolysis and autophagy in neuronal ceroid lipofuscinosis.
    Marques ARA; Di Spiezio A; Thießen N; Schmidt L; Grötzinger J; Lüllmann-Rauch R; Damme M; Storck SE; Pietrzik CU; Fogh J; Bär J; Mikhaylova M; Glatzel M; Bassal M; Bartsch U; Saftig P
    Autophagy; 2020 May; 16(5):811-825. PubMed ID: 31282275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial Dysfunction and Neurodegeneration in Lysosomal Storage Disorders.
    Plotegher N; Duchen MR
    Trends Mol Med; 2017 Feb; 23(2):116-134. PubMed ID: 28111024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of immune abnormalities in lysosomal storage disorders.
    Rigante D; Cipolla C; Basile U; Gulli F; Savastano MC
    Immunol Lett; 2017 Aug; 188():79-85. PubMed ID: 28687233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cln1 gene disruption in mice reveals a common pathogenic link between two of the most lethal childhood neurodegenerative lysosomal storage disorders.
    Chandra G; Bagh MB; Peng S; Saha A; Sarkar C; Moralle M; Zhang Z; Mukherjee AB
    Hum Mol Genet; 2015 Oct; 24(19):5416-32. PubMed ID: 26160911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass spectrometry-based protein profiling to determine the cause of lysosomal storage diseases of unknown etiology.
    Sleat DE; Ding L; Wang S; Zhao C; Wang Y; Xin W; Zheng H; Moore DF; Sims KB; Lobel P
    Mol Cell Proteomics; 2009 Jul; 8(7):1708-18. PubMed ID: 19383612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The birth prevalence of lysosomal storage disorders in the Czech Republic: comparison with data in different populations.
    Poupetová H; Ledvinová J; Berná L; Dvoráková L; Kozich V; Elleder M
    J Inherit Metab Dis; 2010 Aug; 33(4):387-96. PubMed ID: 20490927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy for lysosomal storage diseases: Current clinical trial prospects.
    Kido J; Sugawara K; Nakamura K
    Front Genet; 2023; 14():1064924. PubMed ID: 36713078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging new roles of the lysosome and neuronal ceroid lipofuscinoses.
    Mukherjee AB; Appu AP; Sadhukhan T; Casey S; Mondal A; Zhang Z; Bagh MB
    Mol Neurodegener; 2019 Jan; 14(1):4. PubMed ID: 30651094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulation of autophagy as a common mechanism in lysosomal storage diseases.
    Seranova E; Connolly KJ; Zatyka M; Rosenstock TR; Barrett T; Tuxworth RI; Sarkar S
    Essays Biochem; 2017 Dec; 61(6):733-749. PubMed ID: 29233882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large animal models contribute to the development of therapies for central and peripheral nervous system dysfunction in patients with lysosomal storage diseases.
    Gurda BL; Vite CH
    Hum Mol Genet; 2019 Oct; 28(R1):R119-R131. PubMed ID: 31384936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.